Related Experiment Videos
Treatment of asymptomatic myocardial ischemia
A N Mooss1, D E Hilleman, S M Mohiuddin
1Division of Cardiology, Creighton University School of Medicine, Omaha, Neb., USA.
Insights
Treating asymptomatic myocardial ischemia in coronary artery disease patients may improve outcomes. Revascularization is more effective than medication, with beta-blockers showing superiority among drugs.
Area of Science:
- Cardiology
- Clinical Medicine
- Pharmacology
Background:
- Asymptomatic myocardial ischemia is prevalent in coronary artery disease (CAD) patients.
- Patients with asymptomatic ischemia face increased risks of adverse outcomes.
- Therapeutic strategies for asymptomatic ischemia are under investigation.
Purpose of the Study:
- To review recent randomized controlled trials on treating asymptomatic myocardial ischemia.
- To evaluate the effectiveness of different therapeutic options.
Main Methods:
- Systematic review of recently published randomized controlled trials.
- Analysis of pharmacologic therapies and revascularization strategies.
Main Results:
- Asymptomatic ischemia can be reduced by pharmacologic therapy or revascularization.
- Beta-blockers demonstrate greater efficacy than calcium channel blockers or nitrates.
- Revascularization proves more effective than pharmacologic therapy in managing asymptomatic ischemia.
Conclusions:
- Evidence suggests treating asymptomatic ischemia in CAD patients may improve prognosis.
- Further large-scale studies with broader criteria are necessary due to existing study limitations.
Background:
Asymptomatic myocardial ischemia is commonly observed in patients with coronary artery disease. Numerous studies have shown that patients with asymptomatic ischemia are at higher risk for adverse outcome than those without ischemia. Several recent studies have investigated the therapeutic options available in the management of patients with asymptomatic myocardial ischemia.
Methods:
Recently published randomized controlled trials investigating the treatment of asymptomatic myocardial ischemia were reviewed.
Results:
The controlled trials suggest that (1) asymptomatic ischemia can be suppressed to various degrees using pharmacologic therapy or revascularization, (2) beta-blockers are in general superior to calcium channel blockers or nitrates in relieving asymptomatic ischemia, and (3) revascularization is superior to pharmacologic therapy.
Conclusions:
A growing body of evidence suggests that in patients with coronary artery disease, treatment of asymptomatic ischemia may result in improved outcome. However, because of significant limitations in the published studies, additional studies with large sample sizes and broader inclusion criteria are needed.